BCL2L1 and colonic neoplasm: Induction of pro-apoptotic APAF1, BAK, BIM, and BMF, and loss of anti-apoptotic BCLXL occurred within 12 h of MSP treatment, in both HCT116 and HT29 colon cancer cell lines (Figure 2a).